Literature DB >> 28570163

Direct-Access Online Care for the Management of Atopic Dermatitis: A Randomized Clinical Trial Examining Patient Quality of Life.

Heather Kornmehl1, Sanminder Singh2, Mary Ann Johnson3, April W Armstrong4,5.   

Abstract

BACKGROUND: Atopic dermatitis (AD) is a chronic disease requiring regular follow-up. To increase access to dermatological care, online management of AD is being studied. However, a critical knowledge gap exists in determining AD patients' quality of life in direct-to-patient online models. In this study, we examined quality of life in AD patients managed through a direct-access online model.
MATERIALS AND METHODS: We randomized 156 patients to receiving care through a direct-access online platform or in person. Patients were seen for six visits over 12 months. At each visit, the patients completed Dermatology Life Quality Index/Children's Dermatology Life Quality Index (DLQI/CDLQI), and Short Form (SF-12).
RESULTS: Between baseline and 12 months, the mean (standard deviation, SD) within-group difference in DLQI score in the online group was 4.1 (±2.3); for the in-person group, the within-group difference was 4.8 (±2.7). The mean (SD) within-group difference in CDLQI score in the online group was 4.7 (±2.8); for the in-person group, the within-group difference was 4.9 (±3.1). The mean (SD) within-group difference in physical component score (PCS) and mental component score (MCS) SF-12 scores in the online group was 6.5 (±3.8) and 8.6 (±4.3); for the in-person group, it was 6.8 (±3.2) and 9.1(±3.8), respectively. The difference in the change in DLQI, CDLQI, SF-12 PCS, and SF-12 MCS scores between the two groups was 0.72 (95% confidence interval [90% CI], -0.97 to 2.41), 0.23 (90% CI, -2.21 to 2.67), 0.34 (90% CI, -1.16 to 1.84), and 0.51 (90% CI, -1.11 to 2.13), respectively. All differences were contained within their equivalence margins.
CONCLUSION: Adult and pediatric AD patients receiving direct-access online care had equivalent quality of life outcomes as those see in person. The direct-access online model has the potential to increase access to care for patients with chronic skin diseases.

Entities:  

Keywords:  dermatology; e-health; teledermatology; telehealth

Mesh:

Year:  2017        PMID: 28570163     DOI: 10.1089/tmj.2016.0249

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  9 in total

1.  The role of the nurse in the care and management of patients with atopic dermatitis.

Authors:  Harmieke van Os-Medendorp; Elfie Deprez; Nele Maes; Sheila Ryan; Karina Jackson; Tonya Winders; Linda De Raeve; Christa De Cuyper; Steven Ersser
Journal:  BMC Nurs       Date:  2020-11-04

2.  Patient and Clinician Attitudes Toward Telemedicine for Allergy and Immunology.

Authors:  Allison Ramsey; S Shahzad Mustafa; Jay M Portnoy
Journal:  J Allergy Clin Immunol Pract       Date:  2022-05-23

3.  Recent trends in teledermatology and teledermoscopy.

Authors:  Katie J Lee; Anna Finnane; H Peter Soyer
Journal:  Dermatol Pract Concept       Date:  2018-07-31

4.  Access to Dermatological Care with an Innovative Online Model for Psoriasis Management: Results from a Randomized Controlled Trial.

Authors:  Adam R Ford; Caitlin M Gibbons; Josefina Torres; Heather A Kornmehl; Sanminder Singh; Paulina M Young; Cindy J Chambers; Emanual Maverakis; Cory A Dunnick; April W Armstrong
Journal:  Telemed J E Health       Date:  2018-09-14       Impact factor: 3.536

5.  Online Care Versus In-Person Care for Improving Quality of Life in Psoriasis: A Randomized Controlled Equivalency Trial.

Authors:  April W Armstrong; Adam R Ford; Cindy J Chambers; Emanual Maverakis; Cory A Dunnick; Mary-Margaret Chren; Joel M Gelfand; Caitlin M Gibbons; Brittany M Gibbons; Christianne J Lane
Journal:  J Invest Dermatol       Date:  2018-11-24       Impact factor: 8.551

6.  Effectiveness of Online vs In-Person Care for Adults With Psoriasis: A Randomized Clinical Trial.

Authors:  April W Armstrong; Cindy J Chambers; Emanual Maverakis; Michelle Y Cheng; Cory A Dunnick; Mary-Margaret Chren; Joel M Gelfand; David J Wong; Brittany M Gibbons; Caitlin M Gibbons; Josefina Torres; Andrea C Steel; Elizabeth A Wang; Caitlin M Clark; Sanminder Singh; Heather A Kornmehl; Reason Wilken; Aleksandra G Florek; Adam R Ford; Chelsea Ma; Nazanin Ehsani-Chimeh; Sucharita Boddu; Mayumi Fujita; Paulina M Young; Cesar Rivas-Sanchez; Brenda I Cornejo; Laura C Serna; Eric R Carlson; Christianne J Lane
Journal:  JAMA Netw Open       Date:  2018-10-05

Review 7.  Teledermatology: current indications and considerations for future use.

Authors:  Jacob Beer; Edward Hadeler; Alejo Calume; Howard Gitlow; Keyvan Nouri
Journal:  Arch Dermatol Res       Date:  2020-10-19       Impact factor: 3.017

Review 8.  Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications.

Authors:  Claudio Marasca; Maria Carmela Annunziata; Elisa Camela; Adriana Di Guida; Luigi Fornaro; Matteo Megna; Maddalena Napolitano; Cataldo Patruno; Luca Potestio; Gabriella Fabbrocini
Journal:  J Clin Med       Date:  2022-03-10       Impact factor: 4.241

Review 9.  International Teledermatology Review.

Authors:  Karen McKoy; Saul Halpern; Kudakwashe Mutyambizi
Journal:  Curr Dermatol Rep       Date:  2021-07-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.